Senator Rick Scott has called attention to the United States’ reliance on foreign sources for generic drugs, raising concerns about potential risks to public health and national security. In a letter published in the Wall Street Journal, Scott responded to Jamie Dimon’s “Our Investments for National Security,” urging Congress to address what he described as a dangerous dependence on manufacturers in China and India.
Scott, who chairs the Senate Special Committee on Aging, noted that he has overseen two hearings focused on the threat posed by foreign-made generic drugs. He pointed out that these imports include antibiotics and other life-saving medications relied upon by millions of Americans.
In his letter, Senator Scott wrote, “The U.S. depends on overseas manufacturers for approximately 75% of its essential drug supply. … It wouldn’t take much for Xi Jinping to cause massive and deadly disruptions to everyday American life. … Congress, among other things, needs to strengthen Food and Drug Administration oversight, secure greater transparency on generic drug sourcing, and use the federal government’s buying power to create sustainable supply chains and boost domestic manufacturing of lifesaving and sustaining medications.”
The full text of Senator Scott’s letter is available at the Wall Street Journal.
